id: smoking_cessation_treatment_use_to_NEW:cardiovascular_adverse_events
name: Smoking Cessation Treatment Use â†’ Cardiovascular Adverse Events
from_node:
  node_id: smoking_cessation_treatment_use
  node_name: Smoking Cessation Treatment Use
to_node:
  node_id: NEW:cardiovascular_adverse_events
  node_name: Cardiovascular Adverse Events
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Access to smoking cessation pharmacotherapy through healthcare system'
- 'Step 2: Pharmacological agents may affect cardiovascular parameters'
- 'Step 3: Some cessation medicines carry potential cardiovascular risks'
- 'Step 4: Serious cardiovascular adverse events may occur in vulnerable patients'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Kyla H Thomas et al. 2017. "How do smoking cessation medicines compare with respect
    to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness
    analysis.." https://doi.org/10.1136/bmjopen-2016-015414
  supporting_citations:
  - Previous reviews on cardiovascular safety of cessation medicines
  - Studies on varenicline cardiovascular effects
  - Additional citations require full-text access
  doi: 10.1136/bmjopen-2016-015414
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The protocol includes cardiovascular safety as a secondary outcome. The review will assess
  whether smoking cessation medicines carry differential cardiovascular risks, informing both individual
  prescribing and population-level policy.
moderators:
- name: pre_existing_cardiovascular_disease
  direction: strengthens
  strength: moderate
  description: Patients with pre-existing cardiovascular conditions may be at higher risk for adverse
    events
structural_competency:
  equity_implications: Cardiovascular risk assessment requires adequate healthcare system capacity for
    screening and monitoring. Populations with limited access to preventive care may face greater risks
    from both continued smoking and inadequately monitored cessation attempts.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.366710'
  extraction_confidence: low
  prompt_version: 2.1-canonical-validated
